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Nipah virus (NiV) is an emerging paramyxovirus that can cause lethal respiratory illness in
humans. No vaccine/therapeutic is currently licensed for humans. Human-to-human
transmission was previously reported during outbreaks and NiV could be isolated from
respiratory secretions, but the proportion of cases in Malaysia exhibiting respiratory symptoms
was significantly lower than that in Bangladesh. Previously, we showed that primary human
basal respiratory epithelial cells are susceptible to both NiV-Malaysia (M) and -Bangladesh (B)
strains causing robust pro-inflammatory responses. However, the cells of the human respiratory
epithelium that NiV targets are unknown and their role in NiV transmission and NiV-related lung
pathogenesis is still poorly understood. Here, we characterized NiV infection of the human
respiratory epithelium using a model of the human tracheal/bronchial (B-ALI) and small airway
(S-ALI) epithelium cultured at an air–liquid interface. We show that NiV-M and NiV-B infect
ciliated and secretory cells in B/S-ALI, and that infection of S-ALI, but not B-ALI, results in
disruption of the epithelium integrity and host responses recruiting human immune cells.
Interestingly, NiV-B replicated more efficiently in B-ALI than did NiV-M. These results suggest
that the human tracheal/bronchial epithelium is favourable to NiV replication and shedding, while
inducing a limited host response. Our data suggest that the small airways epithelium is prone to
inflammation and lesions as well as constituting a point of virus entry into the pulmonary
vasculature. The use of relevant models of the human respiratory tract, such as B/S-ALI, is
critical for understanding NiV-related lung pathogenesis and identifying the underlying
mechanisms allowing human-to-human transmission.
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INTRODUCTION
Nipah virus (NiV) is a zoonotic emerging pathogen of the
family Paramyxoviridae, genus Henipavirus (Eaton et al.,
2005). NiV can cause severe acute and often lethal respira-
tory illness and/or encephalitis in humans and animals,
and there are no approved vaccines or therapeutics for
human use. In 1998–1999, a total of 276 human cases
were reported during an outbreak of NiV infection in
Malaysia and Singapore with a 38 % case fatality rate
(CFR) (Chua et al., 2000; Goh et al., 2000). Since 2001,
NiV outbreaks have occurred almost yearly in Bangladesh
and India where the CFR can reach up to 100 % (Harit
et al., 2006; Hossain et al., 2008). NiV infection has
caused severe pneumonia or an acute respiratory-distress-
like syndrome during the outbreaks in Malaysia (Chong
et al., 2002; Goh et al., 2000; Paton et al., 1999) and Ban-
gladesh (Hossain et al., 2008), respectively. Interestingly,
the proportion of human cases in Malaysia exhibiting res-
piratory symptoms was less than 30 % as opposed to more
than 70 % in Bangladesh (Lo & Rota, 2008). Respiratory
distress was significantly associated with death in Bangla-
desh (Hossain et al., 2008), and was not documented in
Malaysia. In addition, human-to-human transmission
was only reported during the outbreaks in Bangladesh
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(Gurley et al., 2007). These data suggest that differences in
virulence and transmission may exist between the geneti-
cally distinct NiV strains from Malaysia (NiV-M) and
from Bangladesh (NiV-B). Histopathological changes in
the lungs of NiV-M-infected cases were characterized by
lesions and inflammation in the small airways (Valbuena
et al., 2014; Wong et al., 2002), and both NiV-M and
NiV-B were isolated from human respiratory secretions
(Chua et al., 2001; Hossain et al., 2008; Mounts et al.,
2001; Tan & Tan, 2001). However, NiV pathogenesis in
the human respiratory tract and specifically the role of
the respiratory epithelium in NiV transmission and in
the inflammation of the lung is largely unknown.
We hypothesize that the respiratory disease and trans-
mission in humans is initiated by NiV infection of
epithelial cells from the lower respiratory tract. Here, we
characterized NiV-M and NiV-B infection of the human
respiratory tract using differentiated epithelial models of
the trachea/bronchi (B-ALI) and small airways (S-ALI)
that closely mimic the anatomy of the human lower
respiratory tract epithelium proximal to the alveoli. Our
results show that ciliated and non-ciliated cells are permiss-
ive to both NiV-M and NiV-B infection, and that infection
induces host responses that recruit human immune cells.
Interestingly, NiV-B replicated more efficiently in the tra-
cheal/bronchial epithelial model compared with NiV-M.
RESULTS
B- and S-ALI mimic the human lower respiratory
epithelium
In order to determine whether these cultures resembled the
human tracheal/bronchial and small airway epithelium, the
phenotype of cells present in the B- and S-ALI cultures was
characterized. B- and S-ALI cultures consisted of pseudo-
stratified columnar and simple cuboidal respiratory-like
epithelium, respectively (Fig. 1a, b). Both models contained
ciliated cells (Figs 1c, d and 2a, d) but only B-ALI con-
tained both Clara secretory cells and mucus-producing
goblet cells (Fig. 2b, c). Goblet cells were not found in
S-ALI (Fig. 2f). Altogether, this suggests that B- and
S-ALI cultures resemble the human lower respiratory
epithelium proximal to the alveoli.
NiV-M and NiV-B replicate in B- and S-ALI
To investigate NiV-M and NiV-B virus replication in the
human tracheal/bronchial and small airway epithelium,
B- and S-ALI cultures were infected at a high and low
m.o.i. of 1 and 0.1, respectively. Regardless of the m.o.i.
used, no cytopathic effect was observed from the apical
side of B-ALI cultures due to infection while both
NiV-M- and NiV-B-infected S-ALI cultures showed evi-
dence of cell detachment from the insert starting at day 4
post-infection (p.i.) (data not shown). At a high m.o.i. in
B-ALI, NiV-B replicated to significantly higher titres than
did NiV-M at days 2 and 5 p.i. (Pv0.05) (Fig. 3a).
NiV-B and NiV-M virus titres peaked respectively at days
5 and 8 p.i., and peak titres were comparable. At a low
m.o.i. in B-ALI, NiV-B also replicated to significantly
higher titres by day 7 p.i. compared with NiV-M
(Pv0.05) (Fig. 3b). Interestingly, NiV-M virus titre
remained under the limit of detection until day 10 p.i.
In S-ALI, infection with a high m.o.i. resulted in higher
replication of NiV-B compared with NiV-M starting at
day 3 p.i., with significant differences at days 3–4 and
7–8 p.i. (Pv0.05) (Fig. 3c). Both NiV-B and NiV-M
virus titres reached a maximum as early as day 3–4 p.i.
but peak titres were about 1 log higher for NiV-B com-
pared with NiV-M. At a low m.o.i. in S-ALI, NiV-B also
replicated with a higher titre compared with NiV-M,
with significant differences at day 6–7 p.i. (Pv0.05)
(Fig. 3d). These results suggest that there are intrinsic
differences between the NiV-M and NiV-B strains in
their ability to replicate in the human tracheal/bronchial
and small airway epithelium, with the NiV-B strain consist-
ently replicating more efficiently, and that both NiV strains
can disrupt the small airway epithelium integrity.
NiV-M and NiV-B have similar cell tropism in B-ALI
To determine which cell types were susceptible to NiV-M
and NiV-B, immunofluorescence staining of viral antigen
and markers for either ciliated, goblet or Clara cells was
performed in B-ALI. Both NiV-M and NiV-B infected all
three cell types as observed in B-ALI (Fig. 4a–f). Altogether,
these results suggest that NiV-M and NiV-B have the same
tropism for differentiated epithelial cells from the human
lower respiratory tract proximal to the alveoli.
NiV-M and NiV-B induce a similar innate immune
response in B- and S-ALI
To gain more insight into the immune response resulting
from NiV-M and NiV-B infection of the human tracheal/
bronchial and small airway epithelium, the levels of a
panel of chemokines/cytokines were quantified in the baso-
lateral media from B- and S-ALI cultures infected at a high
m.o.i. and sampled on day 6 or 7 p.i. (Fig. 5). Among 16
different mediators tested, only the secretion levels of
fractalkine, granulocyte-colony stimulating factor (G-CSF),
granulocyte macrophage-colony stimulating factor (GM-
CSF), IL-6, monocyte chemotactic protein (MCP-1) and
chemokine ligand 10 (CXCL10) were significantly
increased by NiV-M and NiV-B infection in the B- and/
or S-ALI model. IFN-beta secretion levels in B- and
S-ALI remained undetectable (data not shown). Overall,
the baseline cytokine levels were higher in non-infected
S-ALI compared with B-ALI. Despite the slight difference
of virus replication between NiV strains in both B- and
S-ALI, NiV-M and NiV-B induced a similar secretion
level of chemokines/cytokines in B-ALI but at a much
higher level in S-ALI, with the exception of GM-CSF.
The largest increases in cytokine/chemokine secretion
O. Escaffre and others
1078 Journal of General Virology 97
Downloaded from www.microbiologyresearch.org by
IP:  145.5.87.196
On: Mon, 03 Jun 2019 06:36:15
levels due to NiV infection were observed for fractalkine,
G-CSF and IL-6 in S-ALI (Pv0.001), MCP-1 in B-ALI
(Pv0.001) and CXCL-10 in both B- and S-ALI
(Pv0.001) when compared with controls. These results
suggest that NiV-M and NiV-B induce a comparable
pro-inflammatory response in the tracheal/bronchial
epithelium that is distinct from that in the small airway
epithelium proximal to the alveoli.
NiV infection of S-ALI, but not of B-ALI, results in
the recruitment of monocytes
To determine whether NiV-infection-mediated inflamma-
tory response of the tracheal/bronchial and small airway
epithelium can potentially recruit immune cells, cyto-
kines/chemokines secreted in B- and S-ALI were tested
for monocyte chemotactic activity. Since the media used
for differentiated airway cultures interfered with chemo-
taxis, recombinant human cytokines/chemokines, at con-
centrations similar to those in the basolateral media of
NiV-infected B- and S-ALI cultures, were assessed for
monocyte chemotactic activity. No increase of monocyte
migration was observed in the mixtures similar to the
basal side of NiV-M- or NiV-B-infected B-ALI compared
with that in control B-ALI (Fig. 6a). However, an equiva-
lent increase of migrated monocytes occurred in the
mixtures derived from the basal side of NiV-M- and
NiV-B-infected S-ALI, when compared with that in control
S-ALI (Pv0.05) (Fig. 6a). Since the immune response of
S-ALI to NiV-M and NiV-B infection was comparable,
only the cytokine/chemokine concentration levels detected
from NiV-M-infected S-ALI were subsequently tested indi-
vidually, via the use of only one cytokine or chemokine at a
time, against those of control S-ALI for monocyte chemo-
tactic activity. The increased concentrations of fractalkine
and IL-6 were enough to recruit more monocytes
(Pv0.01) (Fig. 6b), while those of G-CSF and CXCL-10
failed to do so (data not shown). These results suggest
that, unlike the tracheal/bronchial respiratory epithelium,
the small airway epithelium proximal to the alveoli can
recruit monocytes via fractalkine and IL-6 secretion in
response to NiV-M and NiV-B infection.
DISCUSSION
NiV is a zoonotic emerging virus that can cause severe and
often fatal respiratory disease and/or encephalitis in
humans (Rockx et al., 2012). We have previously shown
that the respiratory epithelium is an important target
during the early stages of NiV infection (Escaffre et al.,
2013; Rockx et al., 2011; Valbuena et al., 2014); however,
the molecular mechanisms of NiV-mediated pathogenesis
(a)
(b)
(c) (d)
Fig. 1. Imaging of B- and S-ALI epithelium. Cross-section of B-ALI (a) and S-ALI (b) resembling a pseudostratified columnar
and simple cuboidal respiratory-like epithelium, respectively. Magnification 640. Bar, 10 mm. Scanning electron microscopy
of B-ALI (c) and S-ALI (d) displaying cilia from ciliated cells. Magnification 610 000. Bar, 10 mm.
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remain poorly understood. Here, a new model of NiV
infection of the human tracheal/bronchial and small
airway epithelium cultured at an air–liquid interface was
used to investigate NiV-M and NiV-B cell tropism, virus
replication and virus-induced immune response in
epithelium of the lower respiratory tract proximal to
the alveoli.
The human tracheal/bronchial epithelium consists of about
30 %ciliated cells, about 30 % secretory cells that are predom-
inantly goblet cells with a few Clara cells, about 30 % of
undifferentiated basal cells, less than 5 % of indeterminate
cells together with a low percentage of neuroendocrine and
brush cells (Levitzky, 2013; Mercer et al., 1994; Rock et al.,
2010). The small airway epithelium proximal to the alveoli
is populated at more than 50 % by ciliated cells and by a
large proportion of secretory cells that are mostly Clara
cells, but goblet and undifferentiated basal cells are no
longer present. Indeterminate cells and a low population
of neuroendocrine and brush cells may also be found
(Levitzky, 2013; Mercer et al., 1994; Rock et al., 2010). Pre-
vious studies using the same B-ALI model reported
the presence of ciliated cells and secretory goblet cells
(Mitchell et al., 2011; Ren et al., 2012) but their respective
proportions and the presence of other cell types in this
model were, to our knowledge, not further investigated.
Apart from the ciliated cells, the cellular composition
of this particular S-ALI model has not been fully character-
ized either.
In this study, B- and S-ALI cultures resembled the human
tracheal/bronchial and small airway epithelium due to their
respective pseudostratified columnar and simple cuboidal
respiratory-like epithelium arrangement, and also the dis-
tribution of ciliated, goblet and Clara cells (Levitzky,
2013). Several human respiratory epithelial cell models
that resemble B-ALI have previously been used and are
well-accepted for studying respiratory infections (Gerlach
et al., 2013; Lam et al., 2015; Matrosovich et al., 2004;
Rockx et al., 2007) as they are polarized and can be exposed
to viruses in an in vivo-like manner, as opposed to culture-
medium-submerged undifferentiated monolayer cells.
Altogether, our data suggest that B- and S-ALI closely
mimic the human lower respiratory tract epithelium prox-
imal to the alveoli and therefore are biologically relevant
models for studying NiV pathogenesis. Unfortunately, the
matrix-coated microporous membrane of the inserts did
not allow passage of virus particles towards the basal
side, therefore impairing the study of virus penetration
and dissemination via the epithelium.
(a) (d)
(b) (e)
(c) (f)
Fig. 2. Imaging of the most abundant populations of differentiated cells in B- and S-ALI epithelium. In magenta, cross sec-
tions showing cilia from ciliated cells in B-ALI (a) and S-ALI (d), CC10 protein from Clara cells in B-ALI (b) and S-ALI (e),
and Mucin5AC from goblet cells in B-ALI (c). No staining of Mucin5AC in S-ALI (f). Cell nuclei in blue. Magnification 640.
Bars, 10 mm.
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Both NiV-B and NiV-M strains were isolated from human
respiratory secretions (Chua et al., 2001; Hossain et al.,
2008; Mounts et al., 2001; Tan & Tan, 2001) and from
the upper and lower respiratory tract epithelium in ham-
sters (Baseler et al., 2015; de Wit et al., 2014; Rockx
et al., 2011). In our B-ALI model, ciliated, goblet and
Clara cells were susceptible to NiV-M and NiV-B. These
same ciliated and Clara cells were also likely infected in
S-ALI but could not be identified as the infection caused
severe cellular damage. Both strains replicated efficiently
in S-ALI whereas NiV-B replicated significantly faster and
to a higher titre than NiV-M in B-ALI, suggesting intrinsic
differences between NiV strains that result in more efficient
NiV-B replication in the tracheal/bronchial epithelium, but
not the small airways. Such difference of virus replication
level could play a role in the differences observed in
human-to-human transmission during outbreaks (Gurley
et al., 2007). In order to better study the possible intrinsic
differences between the different NiV strains, an in depth
comparison will be required using cultures from multiple
donors.
We previously showed that NiV-M and NiV-B induced
secretion of G-CSF, GM-CSF, IL-1a, IL-6 and IL-8, as
well as CXCL10, MCP-1 and eotaxin, in supernatants of
basal epithelial cells of the trachea/bronchia (NHBE) and
the small airway (SAEC) (Escaffre et al., 2013). In the pres-
ent study, a reduced number of these inflammatory
mediators, including G-CSF, GM-CSF, IL-6, MCP-1, frac-
talkine and CXCL10, also had increased concentration
levels in NiV-M- and NiV-B-infected B- and S-ALI cul-
tures, and were interestingly at much higher levels in the
latter. Therefore, these results suggest that the immune
responses of B- and S-ALI to both NiV strains are more
restricted than those of NHBE and SAEC (Escaffre et al.,
2013), likely due to the differentiation of cells. In agree-
ment with our previous observation in NiV-M- and
NiV-B-infected NHBE or SAEC, there were no significant
differences in cytokine and chemokine induction between
NiV-M- and NiV-B-infected B- or S-ALI cultures (Escaffre
et al., 2013). These data suggest that both NiV strains
induce a similar inflammation of the lower respiratory
tract epithelium distal to the alveoli. However, it is likely
that the strongest inflammation occurs in the small
airway epithelium due to much higher levels of IL-6,
CXCL10, G-CSF and fractalkine than in the tracheal/bron-
chial epithelium. This is supported by the fact that
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Fig. 3. NiV replication in B- and S-ALI at a high and low infective dose. Kinetic of NiV-M (in black) and NiV-B (in grey) replica-
tion in B-ALI (a, b) and S-ALI (c, d) for 10 days p.i. Results are expressed as the mean of three repetitions with the standard
deviation. The horizontal dotted line corresponds to the detection limit. *P,0.05, non-parametric Mann–Whitney test.
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increased secretion levels of these mediators were pre-
viously reported in NiV-M-infected lung grafts exhibiting
syncytia formation in and around primitive alveolar spaces
(Valbuena et al., 2014). In addition, inflammation was only
found in the small airways in NiV-M-infected human cases
(Wong et al., 2002). In hamsters, both NiV strains caused
comparable lesions of the small airways (Baseler et al.,
2015), and IL-6 and CXCL10 gene upregulation in lungs
also correlated with inflammation and pathogenesis (Rockx
et al., 2011).
Histopathological analyses of the lungs from several
human cases of NiV-M infection showed fibrinoid alveo-
lar necrosis but did not report the presence of inflamma-
tory cellular infiltrates into the respiratory epithelium
(Wong et al., 2002). However, these data are only avail-
able from the late stage of disease, while infection of the
respiratory epithelium occurs during the early stages of
infection. Cytokines and chemokines, including those
released from infected B- and S-ALI cultures, can act as
migration factors of immune cells (Baggiolini et al.,
1992; Clahsen & Schaper, 2008; Eaton et al., 2005; Imai
et al., 1997; Luster & Leder, 1993; Taub et al., 1993;
Thelen, 2001; Weissenbach et al., 2004). We showed
that monocyte chemotaxis occurred by cytokines and che-
mokines induced during NiV-M- and NiV-B-infection in
S-ALI, but not in B-ALI samples, and was due to high
concentrations of both IL-6 and fractalkine, two
mediators known to have such role (Clahsen & Schaper,
2008; Imai et al., 1997). Therefore, this suggests that the
small airway respiratory epithelium proximal to alveoli
is itself prone to recruit immune cells such as monocytes
that will eventually differentiate into macrophages due to
inflammation. These data are in line with a previous study
showing macrophage infiltrations in the lumen of the small
airway, but not in the bronchial epithelium, of NiV-M-
infected pigs (Hooper et al., 2001). Macrophages were
also found in the terminal bronchioles and alveolar spaces
of NiV-M- and NiV-B-infected hamsters (DeBuysscher
et al., 2013) and in alveolar spaces of NiV-M-infected
African green monkeys (Bossart et al., 2012). Interestingly,
no IFN-beta was detected in our respiratory epithelium
models as opposed to lung microvasculature endothelial
cells where increased secretion levels caused by NiV-M
correlated with enhanced monocyte and T-lymphocyte
chemotaxis (Lo et al., 2010), suggesting that IFN-beta
plays a role in the vasculitis, not in the pathogenesis, of the
respiratory epithelium.
(a) (d)
(b) (e)
(c) (f)
Fig. 4. NiV tropism for differentiated cells in B-ALI. B-ALI cross-sections showing NiV-M- and NiV-B-infected epithelial cells at
day 4 p.i. Magnification 640. NiV-M-infected (a) ciliated cells (virus in green, cilia in magenta), (b) Clara cells (virus in green,
CC10 protein in magenta) and (c) goblet cells (virus in green, Mucin5AC protein in magenta). NiV-B-infected (d) ciliated cells
(virus in green, cilia in magenta), (e) Clara cells (virus in green, CC10 protein in magenta) and (f) goblet cells (virus in green,
Mucin5AC protein in magenta). Cell nuclei in blue. White arrows show NiV-infected ciliated, Clara or goblet cells. Bars, 10 mm.
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In conclusion, our results show that the tracheal/bronchial
and small airway epithelial models are novel biologically rel-
evant systems to study NiV pathogenesis of the human lower
respiratory tract epithelium. Both NiV-M and NiV-B
infected the same cell types in B- and S-ALI, and induced
similar inflammatory responses that seem to be specific to
each of the tracheal/bronchial and small airway epithelium.
The inflammatory response of NiV-infected S-ALI, but not
B-ALI, resulted in recruitment of immune cells regardless of
the virus strain used. Finally, a high level of NiV replication
in B-ALI, in the absence of inflammatory cell migration,
suggests that the human tracheal/bronchial epithelium is
an opportune location for early replication, aerosolization
and shedding of infectious virus particles. This is consistent
with the fact that human-to-human transmission was
reported during the outbreak in 2004 in Bangladesh where
direct exposure to respiratory secretions of infected patients
was associated with infection (Gurley et al., 2007). In vitro
models mimicking the normal human pulmonary physi-
ology such as B- and S-ALI are essential for understanding
the early host–pathogen interactions and mechanisms of
henipavirus pathogenesis to identify molecular targets and
develop therapeutics as well as to provide fundamental
insights into human-to-human transmission potential.
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METHODS
Viruses and cells. NiV-Malaysia (NiV-M) and NiV-Bangladesh
(NiV-B) viruses were provided by the Special Pathogens Branch
(Centers for Disease Control and Prevention, GA, USA). NiV-M was
originally isolated from the cerebrospinal fluid (CSF) of a patient with
encephalitis during the outbreak in Malaysia and Singapore in 1998.
NiV-B was isolated from a throat swab of a patient exhibiting res-
piratory involvement during the 2004 outbreak in Rajbari district,
Bangladesh. The viruses were propagated and titrated on Vero cells
(CCL-81; ATCC) as previously described (Escaffre et al., 2013).
Normal human bronchial epithelial cells were delivered ready to use
after 2 weeks of differentiation on inserts with an air–liquid interface
(ALI) (MatTek Corporation), providing the B-ALI model. Normal
human small airway epithelial cells derived from the distal airspace
were also cultured in flasks and differentiated for 2 weeks on inserts
with an ALI procedure following the manufacturer’s instructions
(Clonetics), providing the S-ALI model. All cells originated from
biopsies in two healthy donors. Both models were checked, after
2 weeks of ALI procedure, for cilia expression and beating, and for
surfactant secretion before infection, using an upright microscope at
|40 magnification. B- and S-ALI were also checked for barrier
formation by measuring transepithelial electric resistance using the
EVOM2 epithelial voltohmmeter (World Precision Instruments).
Prior to virus inoculation, the apical side of inserts was washed with
250 ml of 1| PBS and infected with 150 ml virus at an m.o.i. of 0.1 or
1 (virus replication kinetics), or 1 (cellular tropism, cytokine/che-
mokine quantification and chemotaxis assay). The m.o.i. was calcu-
lated based on the number of cells originally used to seed the inserts.
Following a 1 h incubation at 37 uC, the apical side of inserts was
rinsed three times with 200 ml of 1| PBS, and all liquid was removed
from the surface in order to maintain the differentiation process. Each
condition was performed with biological triplicates. Sampling for
virus replication kinetics was performed from the apical side by
washing the cells with 200 ml of 1| PBS. Cytokines/chemokines
quantification was performed using samples from the basolateral side.
All infectious work was performed in a class II biological safety
cabinet in a biosafety level 4 laboratory (BSL4) at the Galveston
National Laboratory, University of Texas Medical Branch.
Bright-field and fluorescence microscopy. Cells on inserts were
fixed using 4 % paraformaldehyde (PFA) for 48 h, and then for 24 h
with fresh 4 % PFA before transfer to the BSL2 for paraffin embed-
ding and sectioning. Sections were then processed and imaged with an
Evos XL core when haematoxylin and eosin staining was used, and
with an Olympus IS71 microscope for fluorescence detection.
Primary antibodies against ciliated cells (mouse anti-alpha-tubulin;
Invitrogen), goblet cells (rabbit anti-Muc5AC; Abcam) and Clara
cells (mouse anti-CC10 antibody; Santa Cruz) were detected using a
secondary rhodamine red goat anti-mouse antibody (Jackson
ImmunoResearch), an AF488 goat anti-rabbit antibody or an AF594
goat anti-rabbit antibody (Life Technologies). Viral antigen was
detected using a rabbit anti-NiV-nucleoprotein antibody (kindly
provided by Dr C. Broder, Uniformed Services University, Bethesda,
Maryland) and an AF488 goat anti-rabbit antibody (Life Technol-
ogies) as secondary antibody. DAPI staining (Sigma) was added to
visualize cell nuclei.
Scanning electron microscopy. Cells on inserts were fixed for 48 h
in a mixture of 2.5 % formaldehyde and 0.1 % glutaraldehyde in
0.05 M cacodylate buffer (pH 7.2) containing 0.01 % trinitrophenol
and 0.03 % CaCl2 (primary fixative) and then with fresh primary
fixative for 24 h prior to removal from BSL4. Fixed samples were
washed in 0.1 M cacodylate buffer, post-fixed in 1 % OsO4 in 0.1 M
cacodylate buffer (pH 7.3), dehydrated in ethanol and processed
through hexamethyldisilazane. After being air-dried, filters were
detached, mounted onto the specimen stubs and sputter-coated with
iridium in an Emitech K575x sputter coater at 20 mA for 20 s.
Samples were examined in a Hitachi S4700 field emission scanning
electron microscope (Hitachi High Technologies America) at 2 kV
and instrumental magnifications from|35 to|50 000.
Cytokine/chemokine analysis. Cytokine/chemokine concen-
trations in the supernatant of NiV-M- and NiV-B-infected B- and
S-ALI were determined using a Milliplex Human Cytokine 15 Plex
Immunoassay custom kit (Millipore) and a Verikine-HS Human IFN
Beta ELISA kit (PBL Assay Science). Prior to analysis, samples were
inactivated on dry ice by gamma irradiation (5 Mrad). The assays
were performed according to the manufacturer’s instructions. The
concentration of 16 cytokines [granulocyte-colony stimulating factor
(G-CSF), granulocyte macrophage-colony stimulating factor
(GM-CSF), IFN-a2, IFNb, IFNc, IL-1a, IL-1b, IL-6, IL-8, IL-1RA,
chemokine ligand 10 (CXCL10), eotaxin, monocyte chemotactic
protein (MCP-1), TNF-a, fractalkine (CX3CL1) and vascular endo-
thelial growth factor A (VEGF)] were quantified.
Chemotaxis assay. For analysing immune cell migration, 1.6|106
THP-1 monocytes per sample were washed twice with serum-free
RPMI 1640, warmed to 37 uC, and plated in the top chamber of an
8 mm transwell in 200 ml of serum-free RPMI 1640. Each transwell
insert was then placed into a bottom chamber containing 500 ml of
either serum-free RPMI 1640 (negative control), serum-free RPMI
1640 with mixtures of recombinant human cytokines and chemo-
kines, serum-free RPMI 1640 with one cytokine or chemokine, or
serum-free RPMI 1640 with 50 ng MCP-1 ml21 (positive control).
The cytokines and chemokines (Shenandoah Biotechnology) were
used at concentrations similar to those observed in the basolateral
medium of B- and S-ALI cultures, at day 7 p.i., based on the Milliplex
data. Cytokines and chemokines tested included G-CSF, GM-CSF,
fractalkine, IL-6, MCP-1 and CXCL10 that were tested as a pool or
individually for monocyte chemotactic activity. Monocytes were
allowed to migrate for 3 h at 37 uC in the bottom chamber, and were
then counted using an automated cell counter (Millipore).
Statistical analyses. Comparisons of virus replication levels and
number of migrated monocytes due to chemotaxis were performed
using the non-parametric Mann–Whitney test. Comparison of cyto-
kine/chemokine secretion levels was subjected to a repeated measure
one-way ANOVA test followed by a Bonferroni’s multiple compari-
son test to determine whether treatment means were significantly
different from one another. All data are presented in figures as
means+SD (*Pv0.05, **Pv0.01, ***Pv0.001). Each condition was
performed with biological triplicates.
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